Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
3.000
-0.130 (-4.15%)
At close: Nov 16, 2026, 4:00 PM EST
2.960
-0.040 (-1.33%)
After-hours: Nov 16, 2026, 7:30 PM EST
Coya Therapeutics Employees
Coya Therapeutics had 8 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Coya Therapeutics the 40,801st largest employer in the world and 6,148th in the United States.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$586,128
Profits / Employee
-$3,771,442
Market Cap
70.37M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | 0 | - |
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 2 | 33.33% |
| Dec 31, 2022 | 6 | 0 | - |
| Sep 30, 2022 | 6 | 0 | - |
| Jun 30, 2022 | 6 | - | - |
| Dec 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Rani Therapeutics Holdings | 71 |
| Tenaya Therapeutics | 70 |
| Milestone Pharmaceuticals | 38 |
| Corbus Pharmaceuticals Holdings | 36 |
| NeurAxis | 24 |
| Nutriband | 13 |
| Tiziana Life Sciences | 10 |
| Atara Biotherapeutics | 10 |
COYA News
- 6 days ago - Coya Therapeutics reports Q3 EPS (45c), consensus (35c) - TheFly
- 6 days ago - Coya Therapeutics sees cash runway into 2H27 - TheFly
- 6 days ago - Coya Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update - Business Wire
- 6 days ago - Coya Therapeutics Earnings release: Q3 2026 - Filings
- 6 days ago - Coya Therapeutics Quarterly report: Q3 2026 - Filings
- 6 days ago - Coya Therapeutics Slides: Investor presentation - Filings
- 19 days ago - Coya Therapeutics announces poster presentation on NfL biomarker methodology - TheFly
- 19 days ago - Coya Therapeutics to Present Neurofilament Light Chain (NfL) Biomarker Stratification Methodology in the ALSTARS Trial to Minimize the Impact of Heterogeneity in ALS Clinical Trials at the 2026 Annual NEALS Meeting - Business Wire